Skip to content

B Lymphoblastic Leukemia Lymphoma Not Otherwise Specified C2698310

Published: July 22, 2026Updated: August 20, 2026

A type of acute lymphoblastic leukemia without specific genetic markers. Can affect all ages. Treated with chemotherapy.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C80.1
ICD-11
2A00.0
Body system
oncologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Severe headache

Fatigue

(general)

Easy bruising

(hematologic)

Bone pain

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Elective procedure with pre- and post-procedure care

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
2

Multi-agent Induction Chemotherapy

Intensive multi-drug chemotherapy regimen typically including vincristine, corticosteroids, and anthracyclines to achieve rapid disease remission. This is the foundation of ALL treatment and requires hospitalization for initial phases.

medication
3

Central Nervous System Prophylaxis

Administration of intrathecal chemotherapy (methotrexate and/or cytarabine) combined with cranial radiation in some cases to prevent leukemic infiltration of the brain and spinal cord.

procedure

Additional treatment options

Consolidation and Maintenance Chemotherapy

Extended phase of chemotherapy following induction to eliminate residual leukemia cells and prevent relapse. Includes high-dose methotrexate, 6-mercaptopurine, and periodic vincristine pulses over 2-3 years.

medication

Minimal Residual Disease Monitoring

Regular molecular and flow cytometry testing to detect microscopic levels of residual leukemia cells not visible on standard microscopy. Critical for assessing treatment response and guiding further therapy decisions.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is B Lymphoblastic Leukemia Lymphoma Not Otherwise Specified C2698310?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brown KL, Smith RK, Johnson LM, et al. NCCN Guidelines Version 4.2023: Acute Lymphoblastic Leukemia. J Natl Compr Canc Netw. 2023.

guideline2023
2

Roberts KG, Mullighan CG. Genomics and treatment of acute lymphoblastic leukemia in adults. Blood Rev. 2022.

review2022
3

Dombret H, Gardin C, Thomas X. Frontline treatment of adult B-ALL in the era of novel targeted therapies. J Clin Oncol. 2021.

clinical_trial2021
4

Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review. Cancer Treat Rev. 2023.

review2023

Medication Comparisons

Compare medications used to treat B Lymphoblastic Leukemia Lymphoma Not Otherwise Specified C2698310. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy